Patricia Altea-Manzano

Patricia Altea-Manzano

Auto-generated profile, based on publicly available information

Patricia Altea-Manzano

Centro Andaluz de Biología Molecular y Medicina Regenerativa-CABIMER, CSIC-Universidad de Sevilla-Universidad Pablo de Olavide, 41092 Seville, Spain

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 May 2022 in Nature
Verified
Journal Article
Closed access
PDF file
MRMatteo Rossi
Matteo Rossi
PAPatricia Altea-Manzano
Patricia Altea-Manzano
MDMargherita Demicco
Margherita Demicco
GDGinevra Doglioni
Ginevra Doglioni
LBLaura Bornes
Laura Bornes
SFSarah-Maria Fendt
Sarah-Maria Fendt

2 February 2023 in Nature Cancer
Verified
Journal Article
Open access
PDF file
PAPatricia Altea-Manzano
Patricia Altea-Manzano
GDGinevra Doglioni
Ginevra Doglioni
YLYawen Liu
Yawen Liu
ACAlejandro M. Cuadros
Alejandro M. Cuadros
ENEmma Nolan
Emma Nolan
SFSarah-Maria Fendt
Sarah-Maria Fendt
Metabolic rewiring is often considered an adaptive pressure limiting metastasis formation; however, some nutrients available at distant organs may inherently promote metastatic growth. We find that the lung and liver are lipid-rich environments. Moreover, we observe that pre-metastatic niche formation increases palmitate availability only in the lung, whereas a high-fat diet increases it in both organs. In line with this, targeting palmitate processing inhibits breast cancer-derived lung metastasis formation. Mechanistically, breast cancer cells use palmitate to synthesize acetyl-CoA in a carnitine palmitoyltransferase 1a-dependent manner. Concomitantly, lysine acetyltransferase 2a expression is promoted by palmitate, linking the available acetyl-CoA to the acetylation of the nuclear factor-kappaB subunit p65. Deletion of lysine acetyltransferase 2a or carnitine palmitoyltransferase 1a reduces metastasis formation in lean and high-fat diet mice, and lung and liver metastases from patients with breast cancer show coexpression of both proteins. In conclusion, palmitate-rich environments foster metastases growth by increasing p65 acetylation, resulting in a pro-metastatic nuclear factor-kappaB signaling.

20 January 2025 in Nature Reviews Cancer
Verified
Journal Article
Closed access
PDF file
PAPatricia Altea-Manzano
Patricia Altea-Manzano
ADAmanda Decker-Farrell
Amanda Decker-Farrell
TJTobias Janowitz
Tobias Janowitz
AEAyelet Erez
Ayelet Erez

23 September 2020 in EMBO Reports
Verified
Journal Article
Closed access
PDF file
PAPatricia Altea‐Manzano
Patricia Altea‐Manzano
ACAlejandro M Cuadros
Alejandro M Cuadros
LBLindsay A Broadfield
Lindsay A Broadfield
SFSarah‐Maria Fendt
Sarah‐Maria Fendt

15 November 2022 in Cell Reports
Verified
Journal Article
Open access
JFJuan Fernández-García
Juan Fernández-García
FFFabien Franco
Fabien Franco
SPSweta Parik
Sweta Parik
PAPatricia Altea-Manzano
Patricia Altea-Manzano
APAntonino Alejandro Pane
Antonino Alejandro Pane
SFSarah-Maria Fendt
Sarah-Maria Fendt
T cells dynamically rewire their metabolism during an immune response. We applied single-cell RNA sequencing to CD8+ T cells activated and differentiated in vitro in physiological medium to resolve these metabolic dynamics. We identify a differential time-dependent reliance of activating T cells on the synthesis versus uptake of various non-essential amino acids, which we corroborate with functional assays. We also identify metabolic genes that potentially dictate the outcome of T cell differentiation, by ranking them based on their expression dynamics. Among them, we find asparagine synthetase (Asns), whose expression peaks for effector T cells and decays toward memory formation. Disrupting these expression dynamics by ASNS overexpression promotes an effector phenotype, enhancing the anti-tumor response of adoptively transferred CD8+ T cells in a mouse melanoma model. We thus provide a resource of dynamic expression changes during CD8+ T cell activation and differentiation, and identify ASNS expression dynamics as a modulator of CD8+ T cell differentiation.

1 January 2025 in Nature
Verified
Journal Article
Open access
PDF file
GDGinevra Doglioni
Ginevra Doglioni
JFJuan Fernández-García
Juan Fernández-García
SISebastian Igelmann
Sebastian Igelmann
PAPatricia Altea-Manzano
Patricia Altea-Manzano
ABArnaud Blomme
Arnaud Blomme
SFSarah-Maria Fendt
Sarah-Maria Fendt
Lung metastases occur in up to 54% of patients with metastatic tumours1,2. Contributing factors to this high frequency include the physical properties of the pulmonary system and a less oxidative environment that may favour the survival of cancer cells3. Moreover, secreted factors from primary tumours alter immune cells and the extracellular matrix of the lung, creating a permissive pre-metastatic environment primed for the arriving cancer cells4,5. Nutrients are also primed during pre-metastatic niche formation6. Yet, whether and how nutrients available in organs in which tumours metastasize confer cancer cells with aggressive traits is mostly undefined. Here we found that pulmonary aspartate triggers a cellular signalling cascade in disseminated cancer cells, resulting in a translational programme that boosts aggressiveness of lung metastases. Specifically, we observe that patients and mice with breast cancer have high concentrations of aspartate in their lung interstitial fluid. This extracellular aspartate activates the ionotropic N-methyl-d-aspartate receptor in cancer cells, which promotes CREB-dependent expression of deoxyhypusine hydroxylase (DOHH). DOHH is essential for hypusination, a post-translational modification that is required for the activity of the non-classical translation initiation factor eIF5A. In turn, a translational programme with TGFβ signalling as a central hub promotes collagen synthesis in lung-disseminated breast cancer cells. We detected key proteins of this mechanism in lung metastases from patients with breast cancer. In summary, we found that aspartate, a classical biosynthesis metabolite, functions in the lung environment as an extracellular signalling molecule to promote aggressiveness of metastases.